Targeting Aberrant Learning May Improve Parkinson’s Treatment
mrr5831
Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson’s disease and has the potential to reduce therapy-related side effects, according to a recent study published in Science Advances. The post Targeting Aberrant Learning May Improve Parkinson’s Treatment appeared first on News Center .